48,830
edits
Difference between revisions of "Invasive breast cancer"
Jump to navigation
Jump to search
→Clinical: alt. to tamoxifen
m (→HER2 scoringLester. 2nd Ed. PP.241-2.: sish, fish) |
(→Clinical: alt. to tamoxifen) |
||
| Line 77: | Line 77: | ||
===Clinical=== | ===Clinical=== | ||
*ER & PR status determine whether a patient will get tamoxifen or other estrogen modulators. | *ER & PR status determine whether a patient will get tamoxifen or other estrogen receptor modulators, such as raloxifene (Evista). | ||
*HER2 status determines whether patient will get traztuzumab (Herceptin) or other HER2/neu modulators. | *HER2 status determines whether patient will get traztuzumab (Herceptin) or other HER2/neu modulators. | ||